1,809 results on '"Milnacipran"'
Search Results
2. Milnacipran and Neurocognition, Pain and Fatigue in Fibromyalgia : A 13-week Randomized, Placebo Controlled Cross Over Trial
3. Systemic and Brain Pharmacokinetics of Milnacipran in Mice: Comparison of Intraperitoneal and Intravenous Administration.
4. Efficacy of Hydroxyzine for Patients With Panic Disorder
5. Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease (KETAPAL)
6. Study Evaluated the Effectiveness of Milnacipran to Reduce Pain Levels in Individuals With Chronic Migraine
7. Effect of Milnacipran / Gabapentin in Fibromyalgia
8. Novel Medication as a Potential Smoking Cessation Aid
9. Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder
10. Milnacipran Has an Antihyperalgesic Effect on Cisplatin-Induced Neuropathy.
11. Levomilnacipran in Healthy Males
12. Tricyclic Antidepressants and Serotonin-Norepinephrine Reuptake Inhibitors
13. Milnacipran Ameliorates Executive Function Impairments following Frontal Lobe Traumatic Brain Injury in Male Rats: A Multimodal Behavioral Assessment.
14. Systemic and Brain Pharmacokinetics of Milnacipran in Mice: Comparison of Intraperitoneal and Intravenous Administration
15. Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder
16. A Placebo Controlled, Randomized, Double Blind Trial of Milnacipran for the Treatment of Idiopathic Neuropathy Pain
17. Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme Syndrome (PTLS)
18. Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism
19. Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder
20. Study of Fibromyalgia Treated With Milnacipran
21. Milnacipran Has an Antihyperalgesic Effect on Cisplatin-Induced Neuropathy
22. The Effect of Serotonin-Norepinephrine Reuptake Inhibitor Milnacipran on Anxiety-like Behaviors in Diabetic Mice
23. New Serotonin-Norepinephrine Reuptake Inhibitors and Their Anesthetic and Analgesic Considerations
24. Effect of Milnacipran on Pain in Fibromyalgia (Forest)
25. The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
26. Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD
27. Trial of Levomilnacipran in Geriatric Depression (LMIL)
28. Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia (MyFi)
29. Prediction of Inter-individual Differences in the Response to Morphine Versus Milnacipran in Patients With Sciatica
30. Levomilnacipran Improves Lipopolysaccharide-Induced Dysregulation of Synaptic Plasticity and Depression-Like Behaviors via Activating BDNF/TrkB Mediated PI3K/Akt/mTOR Signaling Pathway.
31. A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
32. Depression during the COVID-19 pandemic (analysis of clinical cases)
33. Savella in Treatment for Provoked Vestibulodynia
34. Milnacipran for Treatment of Pain in Older Adults With Rheumatoid Arthritis
35. A Study to Evaluate the Effects of Milnacipran on Pain Processing and Functional MRI in Patients With Fibromyalgia
36. Serotonin and Norepinephrine Reuptake Inhibitors
37. New Serotonin-Norepinephrine Reuptake Inhibitors and Their Anesthetic and Analgesic Considerations.
38. Role of amino acids at positions 34, 296, and 486 of cytochrome P450 2D6 in the stimulatory and inhibitory effects of psychotropic agents on dopamine formation from p-tyramine.
39. Investigation of the efficiency of various antidepressant replacement regimens in the development of SSRI-induced apathy syndrome
40. Safety and Efficacy of Levomilnacipran Extended Release in Pediatric Patients Aged 7-17 Years with Major Depressive Disorder: Results of Two Phase 3, Randomized, Double-Blind Studies.
41. Milnacipran (Savella) in Irritable Bowel Syndrome (IBS)
42. Drug and Talk Therapy for Fibromyalgia
43. Pain Assessment and Quality of Life in Back Pain Patients: Role of Milnacipran
44. Effect of Milnacipran on Plasma Level of Vascular Endothelial Growth Factor in Major Depression
45. The anticataplectic and REM suppression effect of milnacipran, an SNRI, on human and canine narcolepsy.
46. The Effect of Milnacipran in Patients With Fibromyalgia
47. Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed Patients
48. Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype
49. Predict Antidepressant Responsiveness Using Pharmacogenomics
50. Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.